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Atypical	mitoses	are	not	unusual	in	neoplastic	cells.	
They	 reflect	dysfunction	of	 chromatid	dissociation	
mechanism	during	cell	division	and	possibly	represent	
specific	centrosomal	alterations	involved	in	carcinogene­
sis	[1–3].	It	was	shown	that	high	grade	tumors	consist	
of	aneuploid	cells,	which	are	genomically	unstable	and	
have	high	incidence	of	centrosome	amplification	[4].	
While	genomic	instability	certainly	contributes	to	multi­
step	carcinogenesis,	the	role	of	centrosome	amplifica­
tion	(presence	of	more	than	two	centrosomes	during	
mitosis),	as	event	contributing	in	malignant	transforma­
tion	or	chromosomal	instability,	is	not	clear	at	this	time.	
The	causative	relation	between	abnormal	number	of	
centrosomes,	multipolar	mitoses	and	development	of	
cancer	cell	was	suggested	by	Boveri	at	the	beginning	
of	20th	century.	Today,	there	is	emerging	evidence	that	
centrosome	aberrations	should	be	analyzed,	based	
on	cellular	context	where	 they	occur,	since	 they	can	
also	be	detected	in	non­malignant	cells	[4,	5].	Study	
of	molecular	basis	of	normal	centrosome	duplication	
and	dysfunction	of	this	process	with	oncogenic	stimuli	
is	popular	field	of	modern	research.
Furthermore,	neoplastic	cell	mitoses	are	back	 in	
the	center	of	anti­cancer	research,	since	new	genera­
tions	of	drugs	 targeting	mitosis	were	developed	[6].	
Centrosomal	amplification	can	lead	to	the	assembly	of	
multipolar	spindles,	which	create	spectacular	multipolar	
mitotic	figures.	Herein,	we	present	a	case	of	55­year­old	
man,	who	had	giant	cell	malignant	fibrous	histiocytoma	
(undifferentiated	pleomorphic	sarcoma	with	giant	cells,	
according	to	WHO	Classification),	in	the	retroperitoneal	
region.	During	microscopic	analysis	abundant	atypical	
mitoses	were	observed.	One	such	mitosis	is	depicted	
in	the	Figure.	It	has	close	resemblance	to	Cross.
Figure. Crossing chromosomes	in	atypical	mitosis	(hematoxylin	
and	eosin	stain,	X	1000)
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